Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Bharat Biotech’s intranasal Covid vaccine approved by govt, to be available on CO-WIN soon

by AIP Online Bureau | Dec 23, 2022 | Health, Indian News, Pandemic

It is likely to be rolled out in the national Covid vaccination programme soon. The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries. New Delhi: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union...

DCGI nod to Bharat Biotech’s intranasal Covid vaccine for restricted emergency use

by AIP Online Bureau | Sep 7, 2022 | Health, Indian News, Pandemic

”Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for...

Bharat Biotech says Covaxin booster shot neutralises Omicron

by AIP Online Bureau | Jan 12, 2022 | Facts, Health, Pandemic

“The neutralisation activity of Covaxin-boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant.More than 90% of all individuals boosted with Covaxin showed neutralising antibodies,”Bharat Biotech said...

Recent Posts

  • Income Tax Department cautions taxpayers against rise in fake emails, SMS scams
  • CBDCs more superior to Stablecoins as they satisfy all attributes of money: RBI DG T Rabi Sankar
  • Cabinet nod for Bill seeking to open up civil nuclear sector for private participation
  • Cabinet approves Insurance Amendment Bill for raising FDI cap to 100%, no provision for Composite license
  • Auto industry saw 18.7% YoY growth in passenger vehicle sales in November: SIAM

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy